Mark A. Meltz

This profile gathers the share dealings of Mark A. Meltz in Kinnate Biopharma Inc. In total, 8 filings cover trades dated from 1 September 2022 to 3 April 2024.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Most recently, on 5 April 2024, the filings show a transaction in Kinnate Biopharma Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.